Responses
Therapeutics
Systematic review
Very-low-strength evidence suggests that combining ezetimibe or fibrate with statins is no more effective than high-dose statin monotherapy for reducing all-cause mortality
Compose a Response to This Article
Other responses
No responses have been published for this article.